| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/16/2009 | US20090181044 Novel Flavivirus antigens |
| 07/16/2009 | US20090181043 Method for Producing Human Anti-Thymocyte Immunoglobulins |
| 07/16/2009 | US20090181042 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 07/16/2009 | US20090181041 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 07/16/2009 | US20090181040 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 07/16/2009 | US20090181039 Conjugates with reduced adverse systemic effects |
| 07/16/2009 | US20090181038 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates |
| 07/16/2009 | US20090181037 Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses |
| 07/16/2009 | US20090181036 Pharmaceutical Compositions and Articles of Manufacture Useful in Reversal of a Clinical Episode of an Incurable Disease and Methods of Use Thereof |
| 07/16/2009 | US20090181035 Plexind1 agonists and their use |
| 07/16/2009 | US20090181034 Antibodies and related molecules that bind to psca proteins |
| 07/16/2009 | US20090181033 Antibodies for identifying and/or isolating at least one cell population |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181031 Antibodies to bufadienolides prevent inhibition of Na/K ATPase and prolong survival in shock |
| 07/16/2009 | US20090181030 Use of a preparation based on an antibody directed against a tumor-associated glycosylation |
| 07/16/2009 | US20090181029 Methods for treating interleukin-6 related diseases |
| 07/16/2009 | US20090181028 B-cell epitope peptides of hsp 65, novel amino acid sequences, dna encoding the amino acid sequences of said peptides, antibodies directed against said peptides and different uses thereof in the treatment of inflammatory and autoimmune diseases |
| 07/16/2009 | US20090181027 Anti-IL-12/23p40 Antibodies, Epitopes, Formulations, Compositions, Methods and Uses |
| 07/16/2009 | US20090181026 Tomoregulin-2-antibody compositions and methods for the diagnosis and treatment of Alzheimer's disease |
| 07/16/2009 | US20090181025 T Cell Adhesion Molecule and Antibody Thereto |
| 07/16/2009 | US20090181024 Novel composition and methods for the treatment of immune related diseases |
| 07/16/2009 | US20090181023 Nogo-a binding with enhanced affinity and pharmaceutical use thereof |
| 07/16/2009 | US20090181022 Bispecific binding agents for modulating biological activity |
| 07/16/2009 | US20090181021 Ctsp Cancer-Testis Antigens |
| 07/16/2009 | US20090181020 Methods of Treating Bone-Loss Disorders Using a GM-CSF Antagonist |
| 07/16/2009 | US20090181019 Methods for the Treatment of Gout |
| 07/16/2009 | US20090181018 Humanized anti-ghrelin antibodies |
| 07/16/2009 | US20090181017 Prevention and treatment of complement-associated eye conditions |
| 07/16/2009 | US20090181016 FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME |
| 07/16/2009 | US20090181015 Humanized anti-cd40 antibodies and their methods of use |
| 07/16/2009 | US20090181014 Compositions and methods for the diagnosis and treatment of tumor |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090181012 Method for detecting regulatory t cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the compostion |
| 07/16/2009 | US20090181011 Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors |
| 07/16/2009 | US20090181010 Arginase II: a target for the prevention of atherosclerosis |
| 07/16/2009 | US20090181009 treats hematologic malignancies, cancer; scFv antibody |
| 07/16/2009 | US20090181008 Methods of treating alzheimer's disease |
| 07/16/2009 | US20090180993 Administration of therapeutic viruses |
| 07/16/2009 | US20090180986 Treating unwanted ocular conditions using an ascomycin macrolactam |
| 07/16/2009 | US20090180982 Vaccine immunotherapy for immune suppressed patients |
| 07/16/2009 | US20090180975 Polynucleotide Fragments Of An Infectious Human Endogenous Retrovirus |
| 07/16/2009 | US20090180952 Ligands binding the complex of urokinase-type plasminogen activator (uppa) and its receptor (upar) that inhibit downstream upar interactions: identification and use in diagnosis or therapy |
| 07/16/2009 | CA2711882A1 Improved humanized anti-human .alpha.9-integrin antibody |
| 07/16/2009 | CA2711863A1 Antibody directed against pcrv |
| 07/16/2009 | CA2711771A1 Humanized anti-a9 integrin antibodies and the uses thereof |
| 07/16/2009 | CA2711691A1 Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same |
| 07/16/2009 | CA2711557A1 Anti-cldn6 antibody |
| 07/16/2009 | CA2711334A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/16/2009 | CA2711256A1 Antibody targeting through a modular recognition domain |
| 07/16/2009 | CA2711029A1 Anti mif antibodies |
| 07/16/2009 | CA2710253A1 Method of treating erythropoietin hyporesponsive anemias |
| 07/16/2009 | CA2708406A1 Allergy vaccine composition for mucosal administration |
| 07/15/2009 | EP2078752A2 ALK-1 responds to TGF-beta and signals through SMAD-1 and SMAD-5 |
| 07/15/2009 | EP2078731A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 07/15/2009 | EP2078531A2 Pharmaceutical compositions and methods useful for modulating angiogenesis |
| 07/15/2009 | EP2078086A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 07/15/2009 | EP2078083A1 A novel canine influenza virus and vaccine therefore |
| 07/15/2009 | EP2077863A2 Intrabodies |
| 07/15/2009 | EP2077859A2 Antibody formulation |
| 07/15/2009 | EP2077858A2 Interferon alpha-induced pharmacodynamic markers |
| 07/15/2009 | EP2077857A2 Immunisation method against the 4 dengue serotypes |
| 07/15/2009 | EP2077856A2 Canine lyme disease vaccine |
| 07/15/2009 | EP2077821A1 Compositions and methods for modulating immune responses |
| 07/15/2009 | EP1752141B1 Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer |
| 07/15/2009 | EP1558635B1 Vaccine |
| 07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1259249B1 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof |
| 07/15/2009 | EP1214097B1 Nucleic acids encoding polyepitope polypeptides |
| 07/15/2009 | EP1075272B1 Methods for treating diabetes by inhibiting gdf-8 |
| 07/15/2009 | EP1061949B1 Cytokines and mitogens to inhibit graft-versus-host disease |
| 07/15/2009 | CN101484186A Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists |
| 07/15/2009 | CN101484185A Lyophilized therapeutic peptibody formulations |
| 07/15/2009 | CN101484184A Combination vaccine against streptococcus |
| 07/15/2009 | CN101484183A HLA peptide therapy |
| 07/15/2009 | CN101484182A Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 07/15/2009 | CN101480492A Combined inactivated vaccine for against infectious brunchitis and newcastle disease and preparation method thereof |
| 07/15/2009 | CN100513571C Recombinant helicobacter pylori catalase |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513569C Recombinant helicobacter pylori heat shock protein 60 |
| 07/15/2009 | CN100513560C Method for virus propagation |
| 07/15/2009 | CN100512875C Immune and antiallergic oral product containing IgY and potassium salt, strontium salt added composition, and its preparation method |
| 07/14/2009 | US7560584 Immunomodulatory compounds and methods of use thereof |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560540 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 07/14/2009 | US7560534 For use in therapeutic and diagnostic procedures |
| 07/14/2009 | US7560533 Binding compounds specific for cysteine-rich soluble protein C23 |
| 07/14/2009 | US7560532 Smad6 and uses thereof |
| 07/14/2009 | US7560529 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 07/14/2009 | US7560528 Proteins that comprise the alpha and beta subunit of FSH (Follicle stimulating hormone); makes it possible to ligate and amplify encoding pieces of DNA at the desired positions without the use of restriction enzymes which makes it possible to exclude introns |
| 07/14/2009 | US7560484 Active ingredients of 9,12,13-trihydroxy-10-octadecenoic acid and derivatives as safe and effective vaccine adjuvants; side effects reduction; immunopotentiation; plant extracts; viral diseases; inoculation intranasal, transdermal, oral |
| 07/14/2009 | US7560437 Therapeutic agent for use in the diagnosis and treatment of cancer and cell proliferative disorders |
| 07/14/2009 | US7560431 administering drug biological conjugates used for the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |
| 07/14/2009 | US7560425 Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| 07/14/2009 | US7560278 A recombinant mammalian cell that expresses a mammalian adenovirus E1 functional protein and comprises a porcine circovirus genome |
| 07/14/2009 | US7560267 Dam walls parallel to fluid flow; immobilization |
| 07/14/2009 | US7560251 Media for Clostridium bacterium |
| 07/14/2009 | US7560249 The substrate comprises a carbon source comprising ethanol and an inducer |
| 07/14/2009 | US7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production |